Anti-Plasmodium properties of group IA, IB, IIA and III secreted phospholipases A2 are serum-dependent

Toxicon

Volumn 43, Issue 3, 2004, Pages 311-318

  Guillaume, Carole ^a   Deregnaucourt, Christiane ^a   Clavey, Véronique ^b   Schrével, Joseph ^a  

^a MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^b INSERM   (France)

Author keywords

AlbuMAX II; Lipoproteins; Malaria; Phospholipase A2; Plasmodium falciparum

Indexed keywords

BEE VENOM; PANCREAS EXTRACT; PHOSPHOLIPASE A2; PHOSPHOLIPID; PHOSPHOPROTEIN;

ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; DRUG SCREENING; ERYTHROCYTE; HUMAN; HYDROLYSIS; IC 50; MALARIA; NONHUMAN; PARASITE DEVELOPMENT; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SCHIZONT; SERUM; TROPHOZOITE;

ANIMALS; ANTIMALARIALS; CULTURE MEDIA; HUMANS; MALARIA, FALCIPARUM; PARASITIC SENSITIVITY TESTS; PHOSPHOLIPASES; PLASMODIUM FALCIPARUM; SCORPIONS; SERUM; SNAKE VENOMS; SNAKES;

APOIDEA; PLASMODIUM FALCIPARUM;

EID: 1642338763     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2004.01.006     Document Type: Article

References (27)

1. Bannister L.H., Hopkins J.M., Fowler R.E., Krishna S., Mitchell G.H. A brief illustrated guide to the ultrastructure of Plasmodium falciparum asexual blood stages. Parasitol. Today. 16:2000;427-433.
2. 2 isoform isolated from Bothrops neuwiedii (Yarara chica) venom with novel kinetic and chromatographic properties. Toxicon. 35:1997;1205-1215.
3. 2 induces stage-specific growth arrest of the intraerythrocytic Plasmodium falciparum via modifications of human serum components. J. Biol. Chem. 275:2000;39973-39980.
4. Desjardins R.E., Canfield C.J., Haynes J.D., Chulay J.D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:1979;710-718.
5. 2, a new class of HIV inhibitors that block virus entry into host cells. J. Clin. Invest. 104:1999;611-618.
6. 2 inhibits replication of T-cell tropic HIV-1 via interaction with the CXCR4 chemokine receptor. Mol. Pharmacol. 60:2001;341-347.
7. 2: more than electrostatics and a major role for tryptophan. Curr. Opin. Struct. Biol. 9:1999;428-432.
8. 2 in vascular disease. Circ. Res. 89:2001;298-304.
9. Krugliak M., Deharo E., Shalmiev G., Sauvain M., Moretti C., Ginsburg H. Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo. Exp. Parasitol. 81:1995;97-105.
10. 2 enzymes. Prostaglandins Other Lipid. Mediat. 68/69:2002;3-58.
11. Kumaratilake L.M., Robinson B.S., Ferrante A., Poulos A. Antimalarial properties of n-3 and n-6 polyunsaturated fatty acids: in vitro effects on Plasmodium falciparum and in vivo effects on P. berghei. J. Clin. Invest. 89:1992;961-967.
12. Lambros C., Vanderberg J.P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:1979;418-420.
13. 2 on mouse endothelial (tEnd) and skeletal muscle (C2C12) cells in vitro. Toxicon. 37:1999;145-158.
14. 2 on MCF-7 cells in culture. Toxicon. 31:1993;835-843.
15. 2 in vitro. Biochim. Biophys. Acta. 1024:1990;189-192.
16. 2 from Bothrops asper snake venom. Eur. J. Biochem. 253:1998;452-461.
17. Pasvol G., Wilson R.J., Smalley M.E., Brown J. Separation of viable schizont-infected red cells of Plasmodium falciparum from human blood. Ann. Trop. Med. Parasitol. 72:1978;87-88.
18. 2 enzymes: classification and characterization. Biochim. Biophys. Acta. 1488:2000;1-19.
19. Takayama M., Itoh S., Nagasaki T., Tanimizu I. A new enzymatic method for determination of serum choline-containing phospholipids. Clin. Chim. Acta. 79:1977;93-98.
20. 2 from the cnidarian Adamsia carciniopados. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 132:2002;571-578.
21. Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science. 193:1976;673-675.
22. 2 are indirectly cytolytic in the presence of exogenous phospholipid. Biochim. Biophys. Acta. 1346:1997;193-197.
23. 2 expression and pathogenesis of the sepsis syndrome. Circ. Shock. 39:1993;160-167.
24. 2 expression in adults with malaria. Infect. Immun. 60:1992;3928-3931.
25. 2? Biochimie. 82:2000;815-831.
26. Vial H.J., Ancelin M.L. Malarial lipids. Sherman I.W. Malaria: Parasite Biology, Pathogenesis, and Protection. 1998;159-175 ASM Press, Washington, DC.
27. Zamudio F.Z., Conde R., Arevalo C., Becerril B., Martin B.M., Valdivia H.H., Possani L.D. The mechanism of inhibition of ryanodine receptor channels by imperatoxin I, a heterodimeric protein from the scorpion Pandinus imperator. J. Biol. Chem. 272:1997;11886-11894.